Mon. May 25th, 2026
Spread the love

Nigeria has recorded 649 new cases of COVID-19 pandemic, bringing the total number of infections in the country, as at June 24, to 22,020. The Nigeria Centre for Disease Control (NCDC) made this known on Wednesday through its official Twitter handle.

 

NCDC said that the 649 new confirmed cases were from 23 states, with nine deaths as at June 24. The health agency said that no new state reported a case in the last 24 hours. The NCDC said that Lagos still remained the epicenter of COVID-19, recording the highest number of 250 new cases, followed by Oyo state with 100 new infections.

 

Others were: Plateau-40; Delta-40; Abia-28; Kaduna-27; Ogun-22; Edo-20; Akwa Ibom-18; Kwara-17; FCT-17; Enugu-14; Niger-13; Adamawa-13; Bayelsa-7; Osun-6; Bauchi-6; Anambra-4; Gombe-3; Sokoto-2; while Imo and Kano have one each.

 

The NCDC said that till date, 22,020 cases had been confirmed with 13, 867 active cases; 7,613 cases treated and discharged; 120,108 samples collected and 542 deaths recorded in 35 states and the Federal Capital Territory. The News Agency of Nigeria (NAN) reports that it takes two to 14 days for people who are infected with COVID-19 to develop symptoms.

 

The NCDC said that most infected persons have little or no symptoms, but could spread the disease to others. It stated that COVID-19 spreads very fast, urging Nigerians to take all the necessary precautions to prevent it. (NAN)

 

 Chelsea ends Victor Moses’ loan spell at Inter Milan

 

It appears Victor Moses is on his way back to Stamford Bridge as Chelsea has reportedly refused to extend his stay with Serie A giants, Inter Milan; demanding that Moses should return to London at the end of the Serie A season next month.

 

Speaking to Inter’s Match-day program yesterday before the game against Sassuolo, the former Nigerian star was emotional when he said his intention was to remain at Inter in order to win laurels with Coach Antonio Conte and the fans at San Siro. This prospect now appears dim with the directive from Stamford Bridge. “I love football, it’s been my passion since I was a child,” he explained.

 

“It’s in my blood and what I love doing. The turning point of my career came when I made my debut with Crystal Palace when I was 16. I entered the pitch and the atmosphere was incredible. It made me think that football was my reason for living, something where I could give everything with 100 percent commitment,” Moses said.

 

According to Sky Sport Italia, the Serie A giants look set to lose the Nigerian and Alexis Sanchez before the end of their season because aside Chelsea, Manchester United are also yet to approve the extended stay of their forward in Italy.

 

Both players have been on loan at the San Siro this term and have agreed deals with their respective Premier League clubs to allow them to complete the Serie A campaign. It was learnt that the agreement does not include playing in the Europa League, which is set to be concluded in August.

 

Inter are set to play Spanish side Getafe in the last-16 of the competition, which will commence when the Italian league season has ended. Moses is also set to return to his club, with the Chelsea man’s loan agreement coming to an end after the Serie A season.

 

Inter Milan’s coach, Antonio Conte is understood to be desperate to reach an agreement with both United and the Blues to allow the two players to feature in European competition as he looks to secure the trophy. It was reported that Inter’s CEO Beppe Marotta is working hard behind the scenes to reach an agreement with the two English clubs, which would involve giving them further compensations for the use of their players.

 

Inter are also still within the range of winning the Serie A, although they must make up a nine pint gap to leaders Juventus. They however still have a game in hand. Inter welcomed Sassuolo to the San Siro last night, while second-placed Lazio were also in action at Atalanta Bergamo.

 

 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.